De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome
Open accessAbstract
Dravet syndrome is a severe epilepsy syndrome characterized by infantile onset of therapy-resistant, fever-sensitive seizures followed by cognitive decline. Mutations in SCN1A explain about 75% of cases with Dravet syndrome; 90% of these mutations arise de novo. We studied a cohort of nine Dravet-syndrome-affected individuals without an SCN1A mutation (these included some atypical cases with onset at up to 2 years of age) by using whole-exome sequencing in proband-parent trios. In two individuals, we identified a de novo loss-of-function mutation in CHD2 (encoding chromodomain helicase DNA binding protein 2). A third CHD2 mutation was identified in an epileptic proband of a second (stage 2) cohort. All three individuals with a CHD2 mutation had intellectual disability and fever-sensitive generalized seizures, as well as prominent myoclonic seizures starting in the second year of life or later. To explore the functional relevance of CHD2 haploinsufficiency in an in vivo model system, we knocked down chd2 in zebrafish by using targeted morpholino antisense oligomers. chd2-knockdown larvae exhibited altered locomotor activity, and the epileptic nature of this seizure-like behavior was confirmed by field-potential recordings that revealed epileptiform discharges similar to seizures in affected persons. Both altered locomotor activity and epileptiform discharges were absent in appropriate control larvae. Our study provides evidence that de novo loss-of-function mutations in CHD2 are a cause of epileptic encephalopathy with generalized seizures.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CHD2 mutations have been detected in individuals diagnosed with ASD, intellectual disability, or epilepsy.
“Mutations in CHD2 have been detected in individuals with a diagnosis of ASD (22), ID (73) or epilepsy (82,83,87,89)”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · see citing works
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063 · see citing works
Effective targeted gene ‘knockdown’ in zebrafish
Nasevicius, A., & Ekker, S. C. (2000) · Nature Genetics · doi:10.1038/79951 · Cited by 2,485 · see citing works
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165 · see citing works
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734 · see citing works
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514 · see citing works
Mutations in a new member of the chromodomain gene family cause CHARGE syndrome
Vissers, L. E. L. M., van Ravenswaaij‐Arts, C. M. A., Admiraal, R. J. C., Hurst, J. A., Vries, B. B. A. D., Janssen, I. M., van der Vliet, W. A., Huys, E., de Jong, P. J., Hamel, B. C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1407 · Cited by 1,281 · see citing works
Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders
O’Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., et al. (2012) · Science · doi:10.1126/science.1227764 · Cited by 1,240 · see citing works
Morpholino Antisense Oligomers: Design, Preparation, and Properties
Summerton, J. E., & Weller, D. D. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.187 · Cited by 1,115 · see citing works
Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041 · see citing works
A de novo paradigm for mental retardation.
Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.712 · Cited by 852 · see citing works
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687 · see citing works
Self-citationThe core Dravet syndrome phenotype
Dravet, C. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.02994.x · Cited by 630 · see citing works
Siva, N. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-256b · Cited by 629 · see citing works
Variation in genome-wide mutation rates within and between human families
the 1000 Genomes Project (2011) · Nature Genetics · doi:10.1038/ng.862 · Cited by 581 · see citing works
Dindel: Accurate indel calls from short-read dataPreprint
Albers, C. A., Lunter, G. A., MacArthur, D. G., McVean, G., Ouwehand, W. H., & Durbin, R. M. (2010) · Genome Research · doi:10.1101/gr.112326.110 · Cited by 407 · see citing works
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients
Depienne, C., Trouillard, O., Saint‐Martin, C., Gourfinkel‐An, I., Bouteiller, D., Carpentier, W., Keren, B., Abert, B., Gautier, A., Baulac, S., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062323 · Cited by 363 · see citing works
Self-citationAfrikanova, T., Serruys, A.-S. K., Buenafe, O. E. M., Clinckers, R., Smolders, I. J., de Witte, P. A. M., Crawford, A. D., & Esguerra, C. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054166 · Cited by 280 · see citing works
Self-citationOptimized filtering reduces the error rate in detecting genomic variants by short-read sequencing
Reumers, J., Rijk, P. D., Zhao, H., Liekens, A. M. L., Smeets, D., Cleary, J., Loo, P. V., Bossche, M. J. A. V. D., Catthoor, K., Sabbe, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.2053 · Cited by 234 · see citing works
Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females
Depienne, C., Trouillard, O., Bouteiller, D., Gourfinkel‐An, I., Poirier, K., Rivier, F., Berquin, P. C., Nabbout, R., Chaigne, D., Steschenko, D., et al. (2010) · Human Mutation · doi:10.1002/humu.21373 · Cited by 124 · see citing works
Self-citationMicrodeletions involving theSCN1A gene may be common inSCN1A-mutation-negative SMEI patients
Suls, A., Claeys, K. G., Goossens, D., Harding, B., van Luijk, R., Scheers, S., Deprez, L., Audenaert, D., Dyck, T. V., Beeckmans, S., et al. (2006) · Human Mutation · doi:10.1002/humu.20350 · Cited by 114 · see citing works
Self-citationMutation of the SNF2 family member Chd2 affects mouse development and survival
Marfella, C. G. A., Ohkawa, Y., Coles, A. H., Garlick, D. S., Jones, S. N., & Imbalzano, A. N. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20718 · Cited by 102 · see citing works
Nagarajan, P., Onami, T. M., Rajagopalan, S., Kania, S. A., Donnell, R. L., & Venkatachalam, S. (2009) · Oncogene · doi:10.1038/onc.2008.440 · Cited by 101 · see citing works
Derchansky, M., Jahromi, S. S., Mamani, M., Shin, D. S.-H., Attila Gabor, S. I. K., & Carlen, P. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143065 · Cited by 84 · see citing works
Disruption of chromodomain helicase DNA binding protein 2 (CHD2) causes scoliosis
Kulkarni, S., Nagarajan, P., Wall, J. S., Donovan, D., Donnell, R. L., Ligon, A. H., Venkatachalam, S., & Quade, B. J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32178 · Cited by 68 · see citing works
Recurrent De Novo Mutations of SCN1A in Severe Myoclonic Epilepsy of Infancy
Kearney, J. A., Wiste, A. K., Stephani, U., Trudeau, M., Siegel, A., RamachandranNair, R., Elterman, R. D., Muhle, H., Reinsdorf, J., Shields, W. D., et al. (2006) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.07.009 · Cited by 57 · see citing works
Self-citationPoint mutations as a source of de novo genetic disease
de Ligt, J., Veltman, J. A., & Vissers, L. E. L. M. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.01.007 · Cited by 54 · see citing works
Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency
Capelli, L. P., Krepischi, A. C. V., Gurgel‐Giannetti, J., Mendes, M. F. S. G., Rodrigues, T. C., Varela, M. C., Koiffmann, C. P., & Rosenberg, C. (2011) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2011.10.004 · Cited by 50 · see citing works
Copy number variants in adult patients with Lennox–Gastaut syndrome features
Lund, C., Brodtkorb, E., Røsby, O., Rødningen, O. K., & Selmer, K. K. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.01.009 · Cited by 44 · see citing works
Self-citationEarly onset myoclonic epilepsy and 15q26 microdeletion: Observation of the first case
Veredice, C., Bianco, F., Contaldo, I., Orteschi, D., Stefanini, M. C., Battaglia, D., Lettori, D., Guzzetta, F., & Zollino, M. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02078.x · Cited by 37 · see citing works
A Mutation in the Mouse Chd2 Chromatin Remodeling Enzyme Results in a Complex Renal Phenotype
Marfella, C. G. A., Henninger, N., LeBlanc, S. E., Krishnan, N., Garlick, D. S., Holzman, L. B., & Imbalzano, A. N. (2008) · Kidney & Blood Pressure Research · doi:10.1159/000190788 · Cited by 32 · see citing works
The epileptic encephalopathies
Cross, J. H., & Guerrini, R. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00064-6 · Cited by 26 · see citing works
Self-citationLi, M. M., Nimmakayalu, M. A., Mercer, D., Andersson, H. C., & Emanuel, B. S. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32116 · Cited by 22 · see citing works
Epilepsy in Children—When Should We Think Neurometabolic Disease?
Dhamija, R., Patterson, M. C., & Wirrell, E. C. (2012) · Journal of Child Neurology · doi:10.1177/0883073811435829 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Human Phenotype Ontology in 2017
Köhler, S., Vasilevsky, N., Engelstad, M., Foster, E. D., McMurry, J. A., Aymé, S., Baynam, G. S., Bello, S. M., Boerkoel, C. F., Boycott, K. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1039 · Cited by 757 · see citing works
Self-citationWang, J., Lin, Z.-J., Liu, L., Xu, H., Shi, Y., Yi, Y., He, N., & Liao, W. (2016) · Seizure · doi:10.1016/j.seizure.2016.11.030 · Cited by 488 · see citing works
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
EuroEPINOMICS, R. E. S., Syrbe, S., Hedrich, U. B. S., Riesch, E., Djémié, T., Müller, S., Møller, R. S., Maher, B. H., Hernández-Hernández, L., Synofzik, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3239 · Cited by 275 · see citing works
Self-citationGenetic Control of Expression and Splicing in Developing Human Brain Informs Disease Mechanisms
Walker, R. L., Ramaswami, G., Hartl, C., Mancuso, N., Gandal, M. J., de la Torre-Ubieta, L., Paşaniuc, B., Stein, J. L., & Geschwind, D. H. (2019) · Cell · doi:10.1016/j.cell.2019.09.021 · Cited by 259 · see citing works
GABRA1 and STXBP1 : Novel genetic causes of Dravet syndrome
Carvill, G. L., Weckhuysen, S., McMahon, J. M., Hartmann, C., Møller, R. S., Hjalgrim, H., Cook, J., Geraghty, E., O’Roak, B. J., Petrou, S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000291 · Cited by 262 · see citing works
Self-citationAnimal models in epilepsy research: legacies and new directions
Grone, B. P., & Baraban, S. C. (2015) · Nature Neuroscience · doi:10.1038/nn.3934 · Cited by 258 · see citing works
Advancing epilepsy genetics in the genomic era
Myers, C. T., & Mefford, H. C. (2015) · Genome Medicine · doi:10.1186/s13073-015-0214-7 · Cited by 247 · see citing works
De novo mutations in HCN1 cause early infantile epileptic encephalopathy
Nava, C., Dalle, C., Rastetter, A., Striano, P., de Kovel, C. G. F., Nabbout, R., Cancés, C., Ville, D. M., Brilstra, E. H., Gobbi, G., et al. (2014) · Nature Genetics · doi:10.1038/ng.2952 · Cited by 232 · see citing works
Self-citationGenetics and genomics of autism spectrum disorder: embracing complexity
De Rubeis, S., & Buxbaum, J. D. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv273 · Cited by 208 · see citing works
From genotype to phenotype in Dravet disease
Gataullina, S., & Dulac, O. (2016) · Seizure · doi:10.1016/j.seizure.2016.10.014 · Cited by 179 · see citing works
Dravet syndrome and its mimics: Beyond SCN 1A
Steel, D., Symonds, J. D., Zuberi, S. M., & Brunklaus, A. (2017) · Epilepsia · doi:10.1111/epi.13889 · Cited by 179 · see citing works
Next Generation Sequencing and the Future of Genetic Diagnosis
Lohmann, K., & Klein, C. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0288-8 · Cited by 170 · see citing works
Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future
Sakai, C., Ijaz, S., & Hoffman, E. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00294 · Cited by 164 · see citing works
Genetics of structural and functional brain changes in autism spectrum disorder
Hashem, S., Nisar, S., Bhat, A. A., Yadav, S. K., Azeem, M. W., Bagga, P., Fakhro, K. A., Reddy, R. D., Frenneaux, M. P., & Haris, M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00921-3 · Cited by 161 · see citing works
CHD2variants are a risk factor for photosensitivity in epilepsy
Galizia, E. C., Myers, C. T., Leu, C., de Kovel, C. G. F., Afrikanova, T., Cordero-Maldonado, M. L., Martins, T. G., Jacmin, M., Drury, S., Chinthapalli, K., et al. (2015) · Brain · doi:10.1093/brain/awv052 · Cited by 139 · see citing works
Self-citationPharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
Sourbron, J., Smolders, I. J., de Witte, P. A. M., & Lagae, L. G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00191 · Cited by 139 · see citing works
Dravet Syndrome: Diagnosis and Long-Term Course
Connolly, M. B. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.243 · Cited by 126 · see citing works
Bayat, A., Hjalgrim, H., & Møller, R. S. (2015) · Epilepsia · doi:10.1111/epi.12927 · Cited by 120 · see citing works
Self-citationHelbig, I., López-Hernández, T., Shor, O., Galer, P. D., Ganesan, S., Pendziwiat, M., Rademacher, A., Ellis, C. A., Hümpfer, N., Schwarz, N., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.04.001 · Cited by 120 · see citing works
Self-citationUnderstanding Genotypes and Phenotypes in Epileptic Encephalopathies
Helbig, I., & Tayoun, A. N. A. (2016) · Molecular Syndromology · doi:10.1159/000448530 · Cited by 117 · see citing works
Self-citationAndrade, D. M., Bassett, A. S., Bercovici, E., Borlot, F., Bui, E., CAMFIELD, P. R., Clozza, G. Q., Cohen, E., Gofine, T., Graves, L. E., et al. (2017) · Epilepsia · doi:10.1111/epi.13832 · Cited by 114 · see citing works
Seizing the moment: Zebrafish epilepsy models.
Gawel, K., Langlois, M., Martins, T., van der Ent, W., Tiraboschi, E., Jacmin, M., Crawford, A., & Esguerra, C. (2020) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.010 · Cited by 97 · see citing works
Self-citationFunction Over Form: Modeling Groups of Inherited Neurological Conditions in Zebrafish
Kozol, R. A., Abrams, A. J., James, D. M., Buglo, E., Yan, Q., & Dallman, J. E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00055 · Cited by 108 · see citing works
Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model
Sourbron, J., Schneider, H., Kecskés, A., Liu, Y., Buening, E., Lagae, L. G., Smolders, I. J., & de Witte, P. A. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00342 · Cited by 108 · see citing works
Self-citation<i>CHD2</i> myoclonic encephalopathy is frequently associated with self-induced seizures
Thomas, R. H., Zhang, L. M., Carvill, G. L., Archer, J. S., Heavin, S. B., Mandelstam, S. A., Craiu, D., Berkovic, S. F., Gill, D. S., Mefford, H. C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001305 · Cited by 100 · see citing works
Self-citationVögtle, F. ‐., Brändl, B., Larson, A. A., Pendziwiat, M., Friederich, M. W., White, S. M., Basinger, A., Küçükköse, C., Muhle, H., Jähn, J. A., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.02.014 · Cited by 100 · see citing works
Self-citationThe role of genetic testing in epilepsy diagnosis and management
Weber, Y., Biskup, S., Helbig, K., von Spiczak, S., & Lerche, H. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1335598 · Cited by 87 · see citing works
Self-citationChénier, S., Yoon, G., Argiropoulos, B., Lauzon, J. L., Laframboise, R., Ahn, J. W., Ogilvie, C. M., Lionel, A. C., Marshall, C. R., Vaags, A. K., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-9 · Cited by 94 · see citing works
Hardies, K., Cai, Y., Jardel, C., Jansen, A., Cao, M., May, P., Djémié, T., Camus, C. H. L., Keymolen, K., Deconinck, T., et al. (2016) · Brain · doi:10.1093/brain/aww180 · Cited by 89 · see citing works
Self-citationThe contribution of next generation sequencing to epilepsy genetics
Møller, R. S., Dahl, H. A., & Helbig, I. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1113132 · Cited by 88 · see citing works
Self-citationTDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling
Berson, A., Sartoris, A., Nativio, R., Deerlin, V. M. V., Toledo, J. B., Porta, S., Liu, S., Chung, C., Garcia, B. A., Lee, V. M. ‐., et al. (2017) · Current Biology · doi:10.1016/j.cub.2017.10.024 · Cited by 85 · see citing works
Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
Schoonjans, A., Lagae, L. G., & Ceulemans, B. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615607726 · Cited by 85 · see citing works
The Problem of Rarity: Estimation of Prevalence in Rare Disease
Auvin, S., Irwin, J., Abi-Aad, P., & Battersby, A. (2018) · Value in Health · doi:10.1016/j.jval.2018.03.002 · Cited by 85 · see citing works
Aras, L. M., Isla, J., & Mingorance, A. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.12.028 · Cited by 80 · see citing works
De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures
Myers, C. T., Stong, N., Mountier, E. I., Helbig, K. L., Freytag, S., Sullivan, J. E., Zeev, B. B., Nissenkorn, A., Tzadok, M., Heimer, G., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.08.013 · Cited by 71 · see citing works
Dougnon, G., & Matsui, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147550 · Cited by 71 · see citing works
Genetics of reflex seizures and epilepsies in humans and animals
Italiano, D., Striano, P., Russo, E., Leo, A., Spina, E., Zara, F., Striano, S., Gambardella, A., Labate, A., Gasparini, S., et al. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.01.010 · Cited by 70 · see citing works
Self-citationEpigenetic genes and epilepsy — emerging mechanisms and clinical applications
Van Loo, K. M. J., Carvill, G. L., Becker, A. J., Conboy, K., Goldman, A. M., Kobow, K., Lopes-Cendes, I., Reid, C. A., van Vliet, E. A., & Henshall, D. C. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00693-y · Cited by 68 · see citing works
Chromatin Remodeling Proteins in Epilepsy: Lessons From CHD2-Associated Epilepsy
Lamar, K., & Carvill, G. L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00208 · Cited by 66 · see citing works
De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy
Lange, I., Helbig, K. L., Weckhuysen, S., Møller, R. S., Velinov, M. T., Dolzhanskaya, N., Marsh, E. D., Helbig, I., Devinsky, O., Tang, S., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103909 · Cited by 66 · see citing works
Self-citationMutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia
Rodrı́guez, D., Bretones, G., Quesada, V., Villamor, N., Arango, J. R., López‐Guillermo, A., Ramsay, A. J., Baumann, T., Quirós, P. M., Navarro, A., et al. (2015) · Blood · doi:10.1182/blood-2014-10-604959 · Cited by 64 · see citing works
CHD2 mutations in Lennox–Gastaut syndrome
Lund, C., Brodtkorb, E., Øye, A.-M., Røsby, O., & Selmer, K. K. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.02.005 · Cited by 64 · see citing works
Self-citationPast, present and future of zebrafish in epilepsy research
Yaksi, E., Jamali, A., Verdugo, C. D., & Jurisch‐Yaksi, N. (2021) · FEBS Journal · doi:10.1111/febs.15694 · Cited by 64 · see citing works
Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and diseasePreprint
Alendar, A., & Berns, A. J. M. (2021) · Genes & Development · doi:10.1101/gad.348897.121 · Cited by 65 · see citing works
Evaluating the pathogenic potential of genes with de novo variants in epileptic encephalopathies
He, N., Lin, Z.-J., Wang, J., Wei, F., Meng, H., Liu, X., Chen, Q., Su, T., Shi, Y., Yi, Y., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0011-y · Cited by 61 · see citing works
Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures
Tang, S. S., Addis, L., Smith, A. B., Topp, S. D., Pendziwiat, M., Mei, D., Parker, A. P. J., Agrawal, S., Hughes, E., Lascelles, K., et al. (2020) · Epilepsia · doi:10.1111/epi.16508 · Cited by 59 · see citing works
Self-citationDu, X., An, Y., Yu, L., Liu, R., Qin, Y., Guo, X., Sun, D., Zhou, S., Wu, B.-L., Jiang, Y., et al. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-62 · Cited by 57 · see citing works
Genetic therapeutic advancements for Dravet Syndrome
Chilcott, E. M., Diaz, J. F. A., Bertram, C., Berti, M., & Karda, R. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108741 · Cited by 60 · see citing works
The 16p11.2 homologs fam57ba and doc2a generate certain brain and body phenotypes
McCammon, J. M., Blaker, A. L., Chen, X., & Sive, H. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx255 · Cited by 53 · see citing works
Guerrini, R., Marini, C., & Mantegazza, M. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0267-0 · Cited by 57 · see citing works
Self-citationChromodomain Helicase DNA-Binding Proteins in Stem Cells and Human Developmental Diseases
Micucci, J. A., Sperry, E. D., & Martin, D. M. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0544 · Cited by 56 · see citing works
d’Amora, M., Galgani, A., Marchese, M., Tantussi, F., Faraguna, U., Angelis, F. D., & Giorgi, F. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097702 · Cited by 57 · see citing works
Imaging epilepsy in larval zebrafish
Burrows, D. R. W., Samarut, É., Liu, J., Baraban, S. C., Richardson, M. P., Meyer, M. P., & Rosch, R. E. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.01.006 · Cited by 55 · see citing works
Autism spectrum disorder and epileptic encephalopathy: common causes, many questions
Srivastava, S., & Şahin, M. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9202-0 · Cited by 54 · see citing works
From next-generation sequencing to targeted treatment of non-acquired epilepsies
Møller, R. S., Hammer, T. B., Rubboli, G., Lemke, J. R., & Johannesen, K. M. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1573144 · Cited by 54 · see citing works
Self-citationHengel, H., Bosso-Lefèvre, C., Grady, G., Szenker‐Ravi, E., Li, H., Pierce, S. B., Lebigot, É., Tan, T. T., Eio, M. Y., Narayanan, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14360-7 · Cited by 54 · see citing works
Self-citationHuman CHD2 Is a Chromatin Assembly ATPase Regulated by Its Chromo- and DNA-binding Domains
Liu, J. C., Ferreira, C. G., & Yusufzai, T. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609156 · Cited by 52 · see citing works
Depdc5 knockdown causes mTOR‐dependent motor hyperactivity in zebrafish
de Calbiac, H., Dăbâcan, A., Marsan, E., Tostivint, H., Devienne, G., Ishida, S., Leguern, E., Baulac, S., Muresan, R., Kabashi, E., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.542 · Cited by 50 · see citing works
Self-citationEpigenetic mechanisms in epilepsy
Kobow, K., & Blümcke, I. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00014-4 · Cited by 50 · see citing works
Identification of GSK-3 as a potential therapeutic entry point for epilepsy.
Aourz, N., Serruys, A.-S. K., Chabwine, J. N., Balegamire, P. B., Afrikanova, T., Edrada-Ebel, R., Grey, A. I., Kamuhabwa, A. R., Walrave, L., Esguerra, C. V., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00281 · Cited by 49 · see citing works
Self-citationModels for discovery of targeted therapy in genetic epileptic encephalopathies
Maljevic, S., Reid, C. A., & Petrou, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14134 · Cited by 47 · see citing works
Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features
Niturad, C. E., Lev, D., Kalscheuer, V. M., Charzewska, A., Schubert, J., Lerman‐Sagie, T., Kroes, H. Y., Oegema, R., Traverso, M., Specchio, N., et al. (2017) · Brain · doi:10.1093/brain/awx236 · Cited by 47 · see citing works
Self-citationCunliffe, V. T. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.07.015 · Cited by 46 · see citing works
Li, W., & Mills, A. A. (2014) · Epigenomics · doi:10.2217/epi.14.31 · Cited by 46 · see citing works
Leclercq, K., Afrikanova, T., Langlois, M., Prins, A. D., Buenafe, O. E. M., Rospo, C. C., Eeckhaut, A. V., de Witte, P. A. M., Crawford, A. D., Smolders, I. J., et al. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.03.019 · Cited by 45 · see citing works
Self-citationEpigenetic principles underlying epileptogenesis and epilepsy syndromes
Conboy, K., Henshall, D. C., & Brennan, G. P. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105179 · Cited by 44 · see citing works
Gaweł, K., Turski, W. A., van der Ent, W., Mathai, B. J., Kirstein-Smardzewska, K. J., Simonsen, A., & Esguerra, C. V. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01860-x · Cited by 43 · see citing works
Self-citationWang, J., Wen, Y., Zhang, Q., Yu, S., Chen, Y., Wu, X., Zhang, Y., & Bao, X. (2019) · Seizure · doi:10.1016/j.seizure.2019.01.025 · Cited by 42 · see citing works
Galer, P. D., Ganesan, S., Lewis‐Smith, D., Ruggiero, S. M., Pendziwiat, M., Helbig, K. L., Ellis, C. A., Rademacher, A., Smith, L. A., Poduri, A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.08.003 · Cited by 42 · see citing works
Self-citationPCDH19‐related epileptic encephalopathy in a male mosaic for a truncating variant
Thiffault, I., Farrow, E., Smith, L. D., Lowry, J. A., Zellmer, L., Black, B. T., Abdelmoity, A. T., Miller, N., Soden, S. E., & Saunders, C. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37617 · Cited by 39 · see citing works
CHD2 mutations are a rare cause of generalized epilepsy with myoclonic–atonic seizures
Trivisano, M., Striano, P., Sartorelli, J., Giordano, L., Traverso, M., Accorsi, P., Cappelletti, S., Claps, D., Vigevano, F., Zara, F., et al. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.06.029 · Cited by 39 · see citing works
Self-citationParenti, I., Lehalle, D., Nava, C., Torti, E. E., Leitão, E., Person, R., Mizuguchi, T., Matsumoto, N., Kato, M., Nakamura, K., et al. (2021) · Human Genetics · doi:10.1007/s00439-021-02283-2 · Cited by 38 · see citing works
Self-citationTherapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy
Agbo, J., Ibrahim, Z. G., Magaji, S. Y., Mutalub, Y. B., Mshelia, P. P., & Mhya, D. H. (2023) · Acta Epileptologica · doi:10.1186/s42494-023-00127-2 · Cited by 37 · see citing works
CHD2‐related epilepsy: novel mutations and new phenotypes
Chen, J., Zhang, J., Liu, A., Zhang, L., Li, H., Zeng, Q., Yang, Z., Yang, X., Wu, X., & Zhang, Y. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14367 · Cited by 36 · see citing works
Duszyc, K., Terczyńska, I., & Hoffman‐Zacharska, D. (2014) · Journal of Applied Genetics · doi:10.1007/s13353-014-0243-8 · Cited by 35 · see citing works
Self-citationSantos-Fandila, A., Vázquez, E., Barranco, A., Zafra‐Gómez, A., Navalón, A., Rueda, R., & Ramírez, M. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.07.040 · Cited by 34 · see citing works
Wilson, M., Henshall, D. C., Byrne, S. M., & Brennan, G. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020588 · Cited by 33 · see citing works
Law, C. Y., Chang, S. T.-L., Cho, S. Y., Yau, E. K., Ng, G. S. F., Fong, N.-C., & Lam, C. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.011 · Cited by 31 · see citing works
Zebrafish Models of Epilepsy and Epileptic Seizures
Copmans, D., Siekierska, A., & de Witte, P. A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00026-2 · Cited by 31 · see citing works
Self-citationKobow, K., Reid, C. A., van Vliet, E. A., Becker, A. J., Carvill, G. L., Goldman, A. M., Hirose, S., Lopes‐Cendes, Í., Khiari, H. M., Poduri, A., et al. (2020) · Epileptic Disorders · doi:10.1684/epd.2020.1143 · Cited by 30 · see citing works
Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish
Pensado‐López, A., Veiga-Rúa, S., Carracedo, Á., Allegue, C., & Sanchez, L. E. (2020) · Genes · doi:10.3390/genes11111376 · Cited by 31 · see citing works
Maria, B. D., Balestrini, S., Mei, D., Melani, F., Pellacani, S., Pisano, T., Rosati, A., Scaturro, G. M., Giordano, L., Cantalupo, G., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62548 · Cited by 30 · see citing works
Self-citationLiu, C., Kang, N., Guo, Y., & Gong, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.710203 · Cited by 29 · see citing works
Pleiotropy of autism-associated chromatin regulators
Lasser, M. C., Sun, N., Xu, Y., Wang, S., Drake, S., Law, K., Gonzalez, S., Wang, B., Drury, V., Castillo, O., et al. (2023) · Development · doi:10.1242/dev.201515 · Cited by 29 · see citing works
Epileptic Encephalopathies—Clinical Syndromes and Pathophysiological Concepts
von Deimling, M., Helbig, I., & Marsh, E. D. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0720-7 · Cited by 28 · see citing works
Self-citationReprogramming of the epigenome in neurodevelopmental disorders
Wilson, K., Porter, E. G. P., & Garcia, B. A. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1979457 · Cited by 27 · see citing works
Lessons learned from gene identification studies in Mendelian epilepsy disorders
Hardies, K., Weckhuysen, S., Jonghe, P. D., & Suls, A. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.251 · Cited by 26 · see citing works
Self-citationGenetics and gene therapy in Dravet syndrome
Higurashi, N., Broccoli, V., & Hirose, S. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108043 · Cited by 25 · see citing works
Autism‐linked CHD gene expression patterns during development predict multi‐organ disease phenotypes
Kasah, S., Oddy, C., & Basson, M. A. (2018) · Journal of Anatomy · doi:10.1111/joa.12889 · Cited by 25 · see citing works
Courage, C., Houge, G., Gallati, S., Schjelderup, J., & Rieubland, C. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.06.003 · Cited by 24 · see citing works
Genetic basis of pediatric epilepsy syndromes
Zhang, D., Liu, X., & Deng, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4267 · Cited by 24 · see citing works
Sex, epilepsy, and epigenetics
Qureshi, I., & Mehler, M. F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.019 · Cited by 24 · see citing works
The NuRD complex in neurodevelopment and disease: a case of sliding doors
Boulasiki, P., Tan, X. W., Spinelli, M., & Riccio, A. (2023) · Cells · doi:10.3390/cells12081179 · Cited by 22 · see citing works
Network for Therapy in Rare Epilepsies (NETRE): Lessons From the Past 15 Years
von Stülpnagel, C., van Baalen, A., Borggraefe, I., Eschermann, K., Hartlieb, T., Kiwull, L., Pringsheim, M., Wolff, M., Kudernatsch, M., Wiegand, G., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.622510 · Cited by 21 · see citing works
Self-citationEpilepsy: Old Syndromes, New Genes
Weckhuysen, S., & Korff, C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0447-7 · Cited by 19 · see citing works
Self-citationChromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue
Janowski, M., Milewska, M., Zare, P., & Pękowska, A. (2021) · Pharmaceuticals · doi:10.3390/ph14080765 · Cited by 21 · see citing works
Zebrafish models of candidate human epilepsy-associated genes provide evidence of hyperexcitability
LaCoursiere, C. M., Ullmann, J. F. P., Koh, H. Y., Turner, L. H., Baker, C. M., Robens, B. K., Shao, W., Rotenberg, A., McGraw, C. M., & Poduri, A. (2024) · iScience · doi:10.1016/j.isci.2024.110172 · Cited by 20 · see citing works
Genetic investigations of the epileptic encephalopathies
Myers, C. T., & Mefford, H. C. (2016) · Progress in brain research · doi:10.1016/bs.pbr.2016.04.006 · Cited by 20 · see citing works
Petersen, A. K., Streff, H. E., Tokita, M., & Bostwick, B. L. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38835 · Cited by 20 · see citing works
De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies
Manivannan, S., Roovers, J., Smal, N., Myers, C. T., Türkdoğan, D., Roelens, F., Kanca, O., Chung, H.-L., Scholz, T., Hermann, K., et al. (2021) · Brain · doi:10.1093/brain/awab409 · Cited by 19 · see citing works
Self-citation
- Authors
- Suls, A., Jaehn, J. A., Kecskés, A., Weber, Y., Weckhuysen, S., Craiu, D. C., Siekierska, A., Djémié, T., Afrikanova, T., Gormley, P., von Spiczak, S., Kluger, G., Iliescu, C. M., Talvik, T., Talvik, I., Meral, C., Caglayan, H. S., Giraldez, B. G., Serratosa, J., Lemke, J. R., Hoffman-Zacharska, D., Szczepanik, E., Barisic, N., Komarek, V., Hjalgrim, H., Møller, R. S., Linnankivi, T., Dimova, P., Striano, P., Zara, F., Marini, C., Guerrini, R., Depienne, C., Baulac, S., Kuhlenbäumer, G., Crawford, A. D., Lehesjoki, A.-E., de Witte, P. A. M., Palotie, A., Lerche, H., Esguerra, C. V., De Jonghe, P., Helbig, I., Hendrickx, R., Holmgren, P., Stephani, U., Muhle, H., Pendiziwiat, M., Appenzeller, S., Selmer, K., Brilstra, E., Koeleman, B., Rosenow, F., Leguern, E., Sterbova, K., Magdalena, B., Rodica, G., Arsene, O. T., Diana, B., Guerrero-Lopez, R., Ortega, L., Todorova, A. P., Kirov, A. V., Robbiano, A., Arslan, M., Yiş, U., & Ivanović, V.
- Affiliations
- University of Antwerp (BE)
- Hertie Institute for Clinical Brain Research (DE)
- Carol Davila University of Medicine and Pharmacy (RO)
- KU Leuven (BE)
- Wellcome Sanger Institute (GB)
- Schön Klinik Vogtareuth (DE)
- Tartu University Hospital (EE)
- GATA Haydarpaşa Eğitim Hastanesi (TR)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- University Hospital of Bern (CH)
- University of Southern Denmark (DK)
- University of Helsinki (FI)
- Istituto Giannina Gaslini (IT)
- Meyer Children's Hospital (IT)
- Centre National de la Recherche Scientifique (FR)
- Christian-Albrechts-Universität zu Kiel (DE)
- University of Luxembourg (LU)
- Broad Institute (US)
- ORCID
- Suls, Arvid
- Weber, Yvonne
- Weckhuysen, Sarah
- Craiu, Dana C.
- Siekierska, Aleksandra
- Gormley, Padhraig
- Kluger, Gerhard
- Iliescu, Catrinel M.
- Serratosa, José
- Lemke, Johannes R.
- Hjalgrim, Helle
- Møller, Rikke S.
- Linnankivi, Tarja
- Dimova, Petia
- Striano, Pasquale
- Zara, Federico
- Marini, Carla
- Guerrini, Renzo
- Depienne, Christel
- Baulac, Stéphanie
- Kuhlenbäumer, Gregor
- Lehesjoki, Anna-Elina
- Palotie, Aarno
- Lerche, Holger
- Esguerra, Camila V.
- Helbig, Ingo
- Hendrickx, Rik
- Stephani, Ulrich
- Appenzeller, Silke
- Selmer, Kaja
- Brilstra, Eva
- Koeleman, Bobby
- Rosenow, Felix
- Arslan, Mutluay
- Yiş, Uluç
- Ivanović, Vanja
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 93
- Issue
- 5
- Pages
- 967-975
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC3824114
- OpenAlex
- W2069010410
- Cited by
- 219
- References
- 36
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 17 · 2023: 18 · 2022: 13 · 2021: 20 · 2020: 16 · 2019: 12 · 2018: 15 · 2017: 19 · 2016: 19 · 2015: 29 · 2014: 23
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- Florence Research (University of Florence) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- European Science Foundation
- Deutsche Forschungsgemeinschaft (Le1030/11-1)
- Academy of Finland (141549)
- Deutsche Gesellschaft für Epileptologie
- Folkhälsanin Tutkimussäätiö
- Vlaamse regering
- European Commission (261123)
- Sigrid Juséliuksen Säätiö
- Wellcome Trust (098051, 129680, 213506, 251704, WT089062)
- Universiteit Antwerpen
- Seventh Framework Programme (FP7/2007-2013, HEALTH-F4-2007- 201413)
- Fonds Wetenschappelijk Onderzoek
- Narodowe Centrum Nauki (800/N-ESF-EuroEPINOMICS/10/2011/0)
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- CHD2, Dravet syndrome, myoclonic epilepsy, haploinsufficiency, intellectual disability, epileptiform discharges, locomotor activity
- MeSH terms
- Animals, Child, Cognition Disorders, Seizures, Febrile, DNA-Binding Proteins, Epilepsies, Myoclonic, Female, Humans, Larva, Male, Intellectual Disability, Phenotype, Zebrafish, Cohort Studies, Gene Knockdown Techniques, Young Adult, Haploinsufficiency, Exome, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
